Transdermal Patches for Babies Born with Drug Dependencies
- Conference: Translational Medicine and Bioengineering Conference
- Year: 2017
- Proceeding: 2nd Bioengineering & Translational Medicine Conference
- Group: Poster Submissions
- Time: Saturday, October 28, 2017 - 6:30pm-7:30pm
Newborns born with drug dependencies suffer from finicky eating, jitteriness and trouble settling. Due to the sensitivity of the patient, the best possible method of drug delivery is a transdermal patch releasing medicine in a controlled manner. Currently babies born with methamphetamine dependencies rely on only morphine to mask the symptoms, bringing a need to develop a safer medicine to alleviate their withdrawal symptoms. A drug that would be small enough to passively diffuse through the stratum corneum, and optimize the dopamine production in the brain would allow the babies to naturally produce the dopamine that their bodies are lacking in withdrawal. Due to the developed medicine being made up of naturally occurring dopamine precursors, the risk of the medicine is reduced. Additionally, the use of the patch will reduce the pain and trauma for children. The slow release of the medicine through the natural barrier of the skin optimizes the therapeutic window and creates a low risk of overdose.